Formats
  1. Journal Article (67270)
  2. Meeting Abstract (33961)
  3. Book Section (5131)
  4. Review (3869)
  5. Editorial (2245)
  6. Conference Paper (1528)
  7. Guidelines (686)
  8. Correspondence (679)
  9. Research Letter (565)
  10. Book Whole (346)
  11. Miscellaneous (344)
Groups
  1. Department of Medicine (39470)
  2. GSK Faculty (22632)
  3. Solid Tumor Oncology Division (22264)
  4. Surgery (21420)
  5. Survivorship Research (15905)
  6. Sloan Kettering Institute Faculty (15715)

More Groups

People
  1. Marc Ladanyi (1332)
  2. Robert Motzer (1247)
  3. Victor Reuter (1230)
  4. Howard Scher (1130)
  5. Sergio Giralt (1065)
  6. Murray Brennan (1059)

More People

Years
  1. 2026 (7)
  2. 2025 (2927)
  3. 2024 (5602)
  4. 2023 (5809)
  5. 2022 (6169)
  6. 2021 (5720)

More Years

Publications
  1. Journal of Clinical Oncology (8694)
  2. Blood (5173)
  3. Cancer Research (2703)
  4. International Journal of Radiation Oncology, Biology, Physics (2621)
  5. Laboratory Investigation (1890)
  6. Modern Pathology (1817)

More Publications

Publishers
  1. Elsevier Inc. (13955)
  2. American Society of Clinical Oncology (9291)
  3. Springer (7231)
  4. Nature Publishing Group (6443)
  5. American Association for Cancer Research (6026)
  6. Elsevier Science, Inc. (5556)

More Publishers

Results (116624)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A druggable FOXA1-glucocorticoid receptor transcriptional axis drives tumor growth in NSCLC
    Meeting Abstract

    Dorso, M.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Deferiprone alters macrophage function and metabolism
    Meeting Abstract

    Ackerstaff, E.; Budhu, S.; Winkleman, D. P.; Min, S. S.; Ijoma, J. N.; Serganova, I. S.; Blasberg, R. G.; Merghoub, T.; Koutcher, J. A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Reversibility of tumor adaptations to PI3K inhibition decreases as a function of time
    Meeting Abstract

    Mukherjee, R.; de Stanchina, E.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • PTEN loss-of-function mutations prevalent in HRAS-mutant cancers results in resistance to targeted therapy
    Meeting Abstract

    Nigam, A.; Chatila, W. K.; Krishnamoorthy, G. P.; Ho, A. L.; Fagin, J. A.; Schultz, N. D.; Untch, B. R.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Acute kidney injury induced by allogeneic hematopoietic stem cell transplantation: disease understanding and treatment with nanotechnology-based therapeutics
    Meeting Abstract

    Panagiotakopoulou, M.; Grabarnik, E.; Jaimes, E. A.; van den Brink, M. R.; Heller, D. A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Cancer stem cells are enriched in human recurrent glioblastoma
    Meeting Abstract

    Xie, X. P.; Ganbold, M.; Pedraza, A.; Parada, L.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Role of ENPP1 mediated extracellular cGAMP hydrolysis in cancer metastasis and immune evasion
    Meeting Abstract

    Kwon, J. Y. H.; Li, J.; Duran, M.; Dhanota, N.; Bakhoum, S.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Patient derived organoids model lung adenocarcinoma metastases
    Meeting Abstract

    Liu, Y.; Jones, D.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Targeting c-fos to suppress metastasis inBRMS1v2germline mutantlung adenocarcinoma
    Meeting Abstract

    Liu, Y.; Jones, D.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Comprehensive identification of lineage associated cancer genes in 122 histologies
    Meeting Abstract

    Bandlamudi, C.; Chatila, W. K.; Smith, S. A.; Nandakumar, S.; Bielski, C.; Nguyen, B.; Walch, H. S.; Kreitzer, C. K.; Arora, K. S.; Ngoc, T. T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save